Argos therapeutics stock

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Heat Biologics, Argos Therapeutics seek to bolster stock ... Heat Biologics will split its shares of common stock at a ratio of 1 for 10, while Argos Therapeutics split every 20 shares of common stock into one share. Argos Therapeutics began trading at the Argos Therapeutics Stock Forecast: down to 0.000001 USD ... Historical index on US Stock Market : D-"Should I invest in Argos Therapeutics stock?" "Should I trade "ARGS" stock today?" According to our live Forecast System, Argos Therapeutics, Inc stock is a bad long-term (1-year) investment*. "ARGS" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Argos Therapeutics Announces Closing of $6.0 Million ...

file ( ARGS: Get the latest Argos Therapeutics stock price and detailed information Argos To Terminate ADAPT Study; Plans To Explore Strategic Alternatives.

Argos Therapeutics | EquityNet Doug Plessinger joined Argos Therapeutics in 2011 after serving as a clinical consultant for the company for the previous 4 years. Prior to joining Argos, Mr. Plessinger was an original founder and served as the Executive Vice President and Managing Director for Axcelo MSL Solutions, a Medical Affairs and MSL consulting company. BRIEF-Argos Therapeutics Says Nasdaq To Delist Co's Shares Apr 24, 2018 · * ARGOS THERAPEUTICS - NASDAQ HEARING PANEL DETERMINED TO SUSPEND TRADING IN CO'S COMMON STOCK EFFECTIVE ON APRIL 25, 2018 Source text (bit.ly/2qYbyat) Further company coverage: Argos Therapeutics Inc (NASDAQ:ARGS) Stock Rises on ...

All News for ARGS : - Zacks.com

Argos Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and Search | Nasdaq

Stock Price Forecast for ARGS: Argos Therapeutics holds several positive signals , but we still don't find these to be enough for a buy candidate. At the current 

4 Jan 2017 ABOUT ARGOS · People Powered, Patient Driven INVESTORS · News & Stock Information CONNECT WITH US. Argos Therapeutics, Inc.

Argos Therapeutics Announces Closing of $6.0 Million ...

ABOUT ARGOS – Argos Therapeutics ABOUT ARGOS The Convergence of Precision Medicine and Immunotherapy At Argos®, we believe in the power of the immune system to fight disease. We’re leading the way in developing novel, precision immunotherapy: delivering individualized treatments that recognize each patient’s disease, and arm the immune system to aggressively fight it. We hope our approach will one day Why is Argos Therapeutics (ARGS) Stock is Tanking Today ... On Wednesday, shares of Argos Therapeutics (ARGS) are tanking, down over 22% in mid-morning trading after the company said it is cutting 13% of its workforce to help cut costs. Argos' chief

Apr 02, 2018 · We also recognized $3.2 million in stock-based compensation expense from the acceleration of vesting of stock options and restricted stock held … Argos Therapeutics, Inc. 10-K Apr. 2, 2018 2:13 PM ... ARGOS THERAPEUTICS, INC. ANNUAL REPORT ON FORM 10-K all information in this Annual Report on Form 10-K gives effect to a 1-for-20 reverse stock split of Argos’s common stock that became ARGS - Argos Therapeutics Stock Price - Barchart.com